The enduring success of sildenafil has undeniably transformed the drug landscape. However, wagering in companies heavily reliant on biosimilars and the declining patent rights surrounding this iconic https://tedbphi335237.pointblog.net/the-blue-pill-and-pharmaceutical-companies-a-risky-opportunity-92577508